We exist to improve the lives
of everyone affected by epilepsy

Epilepsy Action position statement on cannabis research

Epilepsy is a condition that can be very difficult to treat. Many people with epilepsy have their condition controlled with epilepsy medicines. For others - around 30 per cent of those with epilepsy - epilepsy medicines are not effective in controlling seizures.

Cannabis is made up of a number of components. It is thought that one of these may have anti-epileptic properties. This component, cannabidiol (CBD), is presently going through limited clinical trials. This study could give more of an insight into the possibility of using a component of cannabis to treat epilepsy. Epilepsy Action therefore welcomes research into this area. It could help our understanding of the anti-epileptic components of cannabis. It may also prove useful in the long term for people whose epilepsy does not respond to current anti-epileptic treatments.

Read more about the clinical trials

There are no comments yet. Be the first to comment...

Contact Author

Epilepsy Action changes lives – thanks to people like you.

We would like to keep you up to date about our work and need your permission to do so.

What would you like to hear about?

How would you like to hear from us?

Please tick one or more options

The details you provide will only be used by Epilepsy Action and its trading company (or those working on our behalf). Epilepsy Action will never swap, share or sell your details.

For more information about how we use and protect your data visit epilepsy.org.uk/privacy

To update your preferences, please contact our supporter care team on 0113 210 8800 or visit epilepsy.org.uk/contact

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
By submitting this form, you accept the Mollom privacy policy.